Navigation Links
Standard treatments for head and neck cancer less effective in HIV-positive patients
Date:1/26/2012

Radiation therapy with or without chemotherapy is less effective for patients with HIV when compared to the recurrence and overall survival rates in patients who do not have HIV, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.

Treating head and neck cancer in HIV-positive patients is a challenge for oncologists. Because of the advancements in treating HIV, these patients are living much longer and therefore have a much higher chance of developing an HIV-related cancer. However, despite using treatments that are successful in HIV-negative cancer patients, HIV-positive patients experience much worse outcomes.

In the largest single institution study of its kind, researchers retrospectively studied 71 HIV-positive head and neck cancer patients treated between 1997 and 2010. Patients were followed for approximately 47 months and the rates of recurrence and overall survival were very high at 69 percent and 55 percent, respectively. Ten percent of patients also developed a second primary malignancy within five years after receiving radiation therapy.

The study authors concluded that neither radiation nor radiation plus chemotherapy, both standard treatments for head and neck cancer, were as effective for HIV-positive patients when compared to HIV-negative patients and that more research was needed to develop treatments that can reduce the risk of recurrence and increase survival rates.

"Treating HIV-positive patients with head and neck cancers is extremely difficult, but becoming much more commonplace due to the advances in therapies that prolong the life of these patients," Waleed Mourad, MD, MSc, PhD, lead author of the study and a radiation oncologist at Beth Israel Medical Center in New York, said. "It is extremely important that we establish multimodality approaches and regimens that are better tailored to improve outcomes in HIV-positive head and neck cancer patients and minimize treated related co-morbidities."


'/>"/>
Contact: Nicole Napoli
nicolen@astro.org
703-839-7336
American Society for Radiation Oncology
Source:Eurekalert

Related medicine news :

1. One-third of antimalarial medicines sampled in 3 African nations found to be substandard
2. Pharmahelper Pleased To Recognize Online Pharmacy Practice Standards Announced By Google Adwords
3. ATS, ERS issue official standards for the quantitative assessment of lung structure
4. Sacred Heart Medical Center Cited for Violation of Safety Standards in H1N1 Prevention
5. Figure Skating Standards Foster Eating Disorders, Says Kimberly Dennis, M.D.
6. Elseviers new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content
7. Innovative Medical Alert Device Sets a New Standard in PERS Industry
8. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
9. MedInformatix EPM and EMR Standardizes Care, Raises Efficiency for Affiliates of Non-Profit Physicians Network
10. Physician calls for more rigorous standards for drugs up for FDA approval
11. Irelands Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... CA (PRWEB) , ... January 24, 2017 , ... Learn ... studies, work, athletics or even in relationships. Course offered by Dr. Carol Francis ... necessary due to limited seating and the many hands-on experiences. , Dr. ...
(Date:1/24/2017)... PA (PRWEB) , ... January 24, 2017 , ... ... advocacy company, announced today that its annual Solutions Series of webinars will start ... industry thought leaders discussing a number of current health and benefits topics, including ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... Bellus Medical, ... company’s team of medical experts. In his new role Dr. Dobke will provide physician ... , Dr. Dobke is the Head of Plastic Surgery and Associate Professor of Surgery ...
(Date:1/24/2017)... ... January 24, 2017 , ... Providing solutions ... new report from the Frank Hawkins Kenan Institute of Private Enterprise ... academics and policy makers identified concrete solutions at the “What’s Next, America?” conference ...
(Date:1/24/2017)... , ... January 24, 2017 , ... The results from ... for everyone and particularly good news for prostate cancer patients: incidents of cancer is ... According to the report the cancer death rate has dropped from its peak of ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... January 24, 2017 www.Financialbuzz.com ... industries in the United States as ... 2016. In addition, Proposition 64, the California Cannabis Legalization Initiative, ... against on November 8, 2016. This outcome means that individuals ... and to grow a certain amount of cannabis for personal ...
(Date:1/24/2017)... , Jan. 24, 2017   QR Pharma ... company developing novel therapies for the treatment of ... the appointment of four world-class key opinion leaders ... appointments join QR Pharma,s previous roster of impressive ... direction to support the development of the breakthrough ...
(Date:1/24/2017)... 2017 Mezzion has filed a suit for ... alleging that Dr. Reddy,s committed fraud relating to Dr. ... Administration (FDA) cGMP practices, and misrepresenting its compliance to ... to Mezzion that it was compliant with FDA regulations, ... suit also states that Dr. Reddy,s misconduct was the ...
Breaking Medicine Technology: